Jörg Hennenlotter

15PUBLICATIONS
32CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Tumour immunologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 15, 2026
Nectin-4 Expression in Muscle-Invasive Bladder Cancer Is Associated with Growth-Related and Inflammatory Signaling Pathways.

|Jul 12, 2025
Metastasis-Specific CpG Island DNA Hypermethylation of the Long Non-Coding RNA Gene 00404 in Renal Cell Carcinoma.

Pouriya Faraj Tabrizi, Inga Schimansky, Inga Peters

|Apr 13, 2024
PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) Therapy.

Moritz Maas, Andreas Hilsendecker, Alexandra Pertoll

|Feb 24, 2024
Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer-An Exploratory Analysis of Clinical and Tumor Biological Significance.

Marko Vukovic, Jorge M Chamlati, Jörg Hennenlotter

|Nov 18, 2023
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification.

Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer

|May 13, 2023
Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy.

Sophia A Hogh-Binder, Diana Klein, Frederik Wolfsperger

Pageof 3

Frequent Collaborators

8 joint publications

Arnulf Stenzl

6 joint publications

Steffen Rausch

3 joint publications

Lucia Berti

2 joint publications

Andras Franko